Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Topic prioritisation
Topic prioritisation
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Prioritisation routing
Prioritisation routing
None selected (376)
Decision
Decision
Awaiting decision (51)
Further information required (26)
Not selected (295)
Apply filters
Showing 51 to 60 of 376
Sort by
Decision date
Title
Apply sorting
Topic prioritisation
Title
Prioritisation routing
Decision
Decision date
Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089]
None selected
Not selected
10 April 2025
Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155]
None selected
Not selected
10 April 2025
Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]
None selected
Not selected
10 April 2025
Doravirine–islatravir for treating HIV-1 in people with virological suppression on antiretroviral therapy [TSID12173]
None selected
Not selected
10 April 2025
Orforglipron for treating type 2 diabetes [TSID12130]
None selected
Not selected
10 April 2025
Botulinum toxin injection to cricopharyngeal muscle for retrograde cricopharyngeal dysfunction (RCPD)
None selected
Not selected
10 April 2025
Infrared lasers for treating onychomycosis
None selected
Further information required
10 April 2025
AHEAD implants for external ear prosthesis
None selected
Not selected
10 April 2025
Doravirine-islatravir for previously untreated HIV-1 infection [TSID12172]
None selected
Not selected
4 April 2025
Doravirine–islatravir for treating HIV-1 in people with virological suppression on bictegravir, emtricitabine and tenofovir alafenamide combination treatment [TSID12171]
None selected
Not selected
4 April 2025
Previous page
1
…
4
5
Current page
6
7
8
…
38
Page
6
of
38
Next page
Results per page
10
25
50
All
Back to top